Conditions: Depression HIV
Keywords: Depression HIV
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 5
Healthy volunteers: no

Brief summary:
To determine the efficacy of escitalopram in treating depression in HIV seropositive women.

Detailed description:
To determine the efficacy of escitalopram in treating depression in HIV seropositive women.

Arms:
arm 1: Placebo arm 2: Escitalopram tablet, 10mg, daily, 9 weeks.

Interventions: intervention 1: Placebo intervention 2: Escitalopram
Intervention descriptions: intervention 1: Placebo daily for duration of double-blind portion of trial intervention 2: Escitalopram 10 mg po daily for duration of double-blind portion of trial

Protocol document: